stock had risen 37.2 pct YTD (Reporting by Anuron Kumar Mitra) Get latest news & live updates on the go on your pc with News App. Download The Times of India news app for your device. (This story has not been edited by timesofindia.com …
But the overall positive tenor in the review clearly impressed investors, who sent the stock $NVO up 3% in pre-market …
Novo Nordisk NVO enjoys a robust presence in the Diabetes care market, with a global value market share of 27%. The company has a leading presence in the total insulin market, and modern and new-generation insulin market, with a …
Considering that the stock moved up roughly 6% to 8% after its last two quarterly ... from developing new drugs to treat the same diseases. Danish company Novo
Dr. Bergenstal has been a research investigator or consultant for Abbott Diabetes Care, Becton Dickinson, Boehringer …
Shares of Denmark-based Novo Nordisk have risen more than 15% over the last year, adjusted for a four-for-one stock split in December 2013. The company is expected to report earnings on Jan. 30.